Pathmaker Neurosystems
Manufacturing · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1 Boston Pl Ste 2600, Boston, Massachuse...Phone Number
(617) 535-7696Website
www.pmneuro.comRevenue
<$5 MillionIndustry
About Pathmaker Neurosystems
PathMaker Neurosystems is a clinical-stage neuromodulation company focused on developing non-invasive devices to treat ALS and other serious neurological disorders. The company aims to commercialize innovative products that suppress neuronal hyperexcitability and activate protein degradation pathways. Utilizing multi-site direct current stimulation technology, PathMaker seeks to restore damaged neural pathways and reduce protein aggregation in motor neurons. Their approach is based on extensive pre-clinical and clinical studies, positioning them at the forefront of a new treatment paradigm for ALS.Explore more
Pathmaker Neurosystems Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Pathmaker Neurosystems
Compare insights from companies similar to Pathmaker Neurosystems, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Pathmaker Neurosystems Tech Stack
A closer look at the technologies used by Pathmaker Neurosystems
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Pathmaker Neurosystems
Sign Up For FreeTo access detailed company insights
PathMaker Neurosystems is a clinical-stage neuromodulation company focused on developing non-invasive devices to treat ALS and other serious neurological disorders. The company aims to commercialize innovative products that suppress neuronal hyperexcitability and activate protein degradation pathways. Utilizing multi-site direct current stimulation... Read More
